These were the seven biggest deals closed or announced in 2018:
1. Takeda’s planned takeover of Shire: $77 billion
2. Cigna’s acquisition of Express Scripts: $68.5 billion
3. GlaxoSmithKline’s agreement to purchase of Novartis’s stake in a consumer health joint venture: $13 billion
4. Sanofi’s agreement to buy Bioverati: $10.9 billion
5. KKR’s acquisition of Nashville, Tenn.-based Envision Healthcare: $9.5 billion
6. Celgene’s acquisition of Juno: $8.9 billion
7. Novartis’ agreement to acquire AveXis: $8.1 billion
Click here to read more about the companies and how the transactions could shape healthcare.
More articles on transactions/valuation:
PE deals in healthcare increase 200%+ in a decade — What’s in store for 2019?
5 predictions for ophthalmology PE in 2019 — AmSurg, USPI & more
Conemaugh Health System breaks ground on outpatient center — 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
